CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Acquisition of exclusive commercialization rights for European markets
BHL will undertake the development and supply of these molecules
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The agreement sets terms under which POC will manufacture the product or receive royalties
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
The CDCCs are strategically positioned in regions identified as high-impact areas
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Subscribe To Our Newsletter & Stay Updated
